Fecal S100A12 concentration predicts a lack of response to treatment in dogs affected with chronic enteropathy.

No abstract is available for this paper.

• Publication year

  2016

• Venue

  The Veterinary Journal

• Publication date

  2016-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.tvjl.2016.03.001PMID 27017054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Validation of an enzyme-linked immunosorbent assay (ELISA) for the measurement of canine S100A12.

  2016cited by this paper
• Accuracies of Serum and Fecal S100 Proteins (Calprotectin and Calgranulin C) to Predict the Response to TNF Antagonists in Patients with Crohn's Disease

  2015cited by this paper
• Diagnosis of Small Intestinal Disorders in Dogs and Cats

  2015cited by this paper
• Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.

  2014cited by this paper
• Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.

  2014cited by this paper
• Improving Relapse Prediction in Inflammatory Bowel Disease by Neutrophil-Derived S100A12

  2013cited by this paper
• S100A12: A noninvasive marker of inflammation in inflammatory bowel disease

  2013cited by this paper
• Diagnosis of Small Intestinal Disorders in Dogs and Cats

  2013cited by this paper
• American College of Veterinary Internal Medicine Consensus Statements Endoscopic , Biopsy , and Histopathologic Guidelines for the Evaluation of Gastrointestinal Inflammation in Companion Animals

  2010cited by this paper
• Monitoring disease activity by stool analyses: from occult blood to molecular markers of intestinal inflammation and damage

  2009cited by this paper
• RAGE signaling sustains inflammation and promotes tumor development

  2008cited by this paper
• Clinical signs, histology, and CD3-positive cells before and after treatment of dogs with chronic enteropathies.

  2008cited by this paper
• Evaluation of clinical, macroscopic, and histopathologic response to treatment in nonhypoproteinemic dogs with lymphocytic-plasmacytic enteritis.

  2007cited by this paper
• Chronic enteropathies in dogs: evaluation of risk factors for negative outcome.

  2007cited by this paper
• Fecal S100A12: A novel noninvasive marker in children with Crohn's disease

  2006cited by this paper
• Neutrophil derived human S100A12 (EN-RAGE) is strongly expressed during chronic active inflammatory bowel disease

  2003cited by this paper
• Expression of S100A12 (EN-RAGE) in cystic fibrosis

  2003cited by this paper
• Expression of the pro-inflammatory protein S100A12 (EN-RAGE) in rheumatoid and psoriatic arthritis.

  2003cited by this paper
• A scoring index for disease activity in canine inflammatory bowel disease.

  2003cited by this paper
• Total chemical synthesis and chemotactic activity of human S100A12 (EN‐RAGE)

  2001cited by this paper
• RAGE mediates a novel proinflammatory axis: a central cell surface receptor for S100/calgranulin polypeptides.

  1999cited by this paper
• Calgranulin C Has Filariacidal and Filariastatic Activity

  1999cited by this paper

• ACVIM-endorsed statement: consensus statement and systematic review on guidelines for the diagnosis and treatment of chronic inflammatory enteropathy in dogs.

  2026cites this paper
• Endoscopic Biopsy Assessment of Neoplastic Prevalence in Dogs with Chronic Diarrhoea and Non-Suggestive Ultrasound Findings

  2025cites this paper
• Retrospective evaluation of short- and medium-term therapeutic response to different immunosuppressive and dietary approaches in 148 dogs diagnosed with immunosuppressant-responsive enteropathy

  2025cites this paper
• Effects of a Saccharomyces cerevisiae-Derived Postbiotic in Adult Labrador Retrievers Undergoing Exercise and Transport Stress

  2024cites this paper
• Intestinal Biomarkers and Their Importance in Canine Enteropathies

  2024cites this paper
• Efficacy and tolerance of oral versus parenteral cyanocobalamin supplement in hypocobalaminaemic dogs with chronic enteropathy: a controlled randomised open-label trial.

  2024cites this paper
• The effects of torula yeast as a protein source on apparent total tract digestibility, inflammatory markers, and fecal microbiota dysbiosis index in Labrador Retrievers with chronically poor stool quality.

  2024cites this paper
• Serum/Faecal S100A12, CRP and lactoferrin can be used to distinguish ınfectious and non‐ınfectious canine diarrhoea

  2023cites this paper
• Association of folate concentrations with clinical signs and laboratory markers of chronic enteropathy in dogs

  2023cites this paper
• Fecal S100A12 concentrations in cats with chronic enteropathies

  2023cites this paper
• Canine chronic enteropathy—Current state-of-the-art and emerging concepts

  2022cites this paper
• Relationship between serum cobalamin concentration and endoscopic ileal appearance and histology in dogs with chronic inflammatory enteropathy

  2022cites this paper
• Chronic Enteropathy in Dogs—Epidemiologic Aspects and Clinical Characteristics of Dogs Presenting at Two Swedish Animal Hospitals

  2022cites this paper
• Intestinal S100/Calgranulin Expression in Cats with Chronic Inflammatory Enteropathy and Intestinal Lymphoma

  2022cites this paper
• Effects of Canine-Obtained Lactic-Acid Bacteria on the Fecal Microbiota and Inflammatory Markers in Dogs Receiving Non-Steroidal Anti-Inflammatory Treatment

  2022cites this paper
• Cholestyramine treatment in two dogs with presumptive bile acid diarrhoea: a case report

  2021cites this paper
• Circulating Endocannabinoids as Diagnostic Markers of Canine Chronic Enteropathies: A Pilot Study

  2021cites this paper
• Clinical signs, duodenal histopathological grades, and serum high‐mobility group box 1 concentrations in dogs with inflammatory bowel disease

  2021cites this paper
• Faecal proteomics in the identification of biomarkers to differentiate canine chronic enteropathies.

  2021cites this paper
• From Bench Top to Clinics: How New Tests Can Be Helpful in Diagnosis and Management of Dogs with Chronic Enteropathies.

  2021cites this paper
• Association of clinical characteristics and lifestyle factors with fecal S100/calgranulin concentrations in healthy dogs

  2021cites this paper
• Association between serum soluble receptor for advanced glycation end-products (RAGE) deficiency and severity of clinicopathologic evidence of canine chronic inflammatory enteropathy

  2020cites this paper
• Important and Novel Laboratory Parameters and Biomarkers for Canine Chronic Enteropathy

  2020cites this paper
• Analytical validation of an enzyme-linked immunosorbent assay for the quantification of S100A12 in the serum and feces of cats.

  2019cites this paper
• Mucosal immunity and gut microbiota in dogs with chronic enteropathy.

  2019cites this paper
• Fecal Proteomic Analysis in Healthy Dogs and in Dogs Suffering from Food Responsive Diarrhea

  2019cites this paper
• Mucosal expression of S100A12 (calgranulin C) and S100A8/A9 (calprotectin) and correlation with serum and fecal concentrations in dogs with chronic inflammatory enteropathy.

  2019cites this paper
• Review of cobalamin status and disorders of cobalamin metabolism in dogs

  2019cites this paper
• Chronic Enteropathy In Canines: Prevalence, Impact And Management Strategies

  2019cites this paper
• VMRR_A_162774 203..214

  2019cites this paper
• Association of fecal calprotectin concentrations with disease severity, response to treatment, and other biomarkers in dogs with chronic inflammatory enteropathies

  2018influential citation
• Comparison of efficacy of oral and parenteral cobalamin supplementation in normalising low cobalamin concentrations in dogs: A randomised controlled study.

  2018cites this paper
• Determination and Evaluation of Mucosal Matrix Metalloproteinase -2 and -9, S100A12 and Myeloperoxidase in the Intestine of Dogs with Chronic Enteropathies and Healthy Beagles

  2018influential citation
• Clinical utility of currently available biomarkers in inflammatory enteropathies of dogs

  2018cites this paper
• Effect of selected gastrointestinal parasites and viral agents on fecal S100A12 concentrations in puppies as a potential comparative model

  2018cites this paper
• S100A12 concentrations and myeloperoxidase activities are increased in the intestinal mucosa of dogs with chronic enteropathies

  2018cites this paper
• Comparison of efficacy of oral and parenteral cobalamin supplementation in normalising low cobalamin concentrations in dogs: A randomised controlled study

  2018cites this paper
• Review on use of biomarkers in small animal disease diagnosis

  2018cites this paper
• Chronisch-entzündliche Darmerkrankungen beim Hund – diagnostische und therapeutische Aspekte

  2017cites this paper
• Chronic enteropathy food-and immunosuppressant-responsive : comparison of clinicopathological findings and follow-up

  2017cites this paper
• Histopathologic Characteristics of Intestinal Biopsy Samples from Dogs With Chronic Inflammatory Enteropathy With and Without Hypoalbuminemia

  2017cites this paper
• Enteropatia cronica dieto- e immuno-responsiva nel cane: aspetti clinicopatologici e follow-up a confronto

  2017cites this paper
• Recent developments in veterinary diagnostics: Current status and future potential.

  2016cites this paper